Literature DB >> 9159151

Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

V Yusibov1, A Modelska, K Steplewski, M Agadjanyan, D Weiner, D C Hooper, H Koprowski.   

Abstract

The coat protein (CP) of alfalfa mosaic virus was used as a carrier molecule to express antigenic peptides from rabies virus and HIV. The antigens were separately cloned into the reading frame of alfalfa mosaic virus CP and placed under the control of the subgenomic promoter of tobacco mosaic virus CP in the 30BRz vector. The in vitro transcripts of recombinant virus with sequences encoding the antigenic peptides were synthesized from DNA constructs and used to inoculate tobacco plants. The plant-produced protein (virus particles) was purified and used for immunization of mice. Both antigens elicited specific virus-neutralizing antibodies in immunized mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159151      PMCID: PMC20857          DOI: 10.1073/pnas.94.11.5784

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Antigen chimaeras of poliovirus as potential new vaccines.

Authors:  K L Burke; G Dunn; M Ferguson; P D Minor; J W Almond
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

3.  A functional equivalence of top component a RNA and coat protein in the initiation of infection by alfalfa mosaic virus.

Authors:  J F Bol; L van Vloten-Doting; E M Jaspars
Journal:  Virology       Date:  1971-10       Impact factor: 3.616

4.  Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

Authors:  S D Rencher; K S Slobod; D H Dawson; T D Lockey; J L Hurwitz
Journal:  AIDS Res Hum Retroviruses       Date:  1995-09       Impact factor: 2.205

5.  N-terminal basic amino acids of alfalfa mosaic virus coat protein involved in the initiation of infection.

Authors:  V M Yusibov; L S Loesch-Fries
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

6.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

7.  Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.

Authors:  T J Wiktor; R I Macfarlan; C M Foggin; H Koprowski
Journal:  Dev Biol Stand       Date:  1984

8.  Expression of the rabies virus glycoprotein in transgenic tomatoes.

Authors:  P B McGarvey; J Hammond; M M Dienelt; D C Hooper; Z F Fu; B Dietzschold; H Koprowski; F H Michaels
Journal:  Biotechnology (N Y)       Date:  1995-12

9.  Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus.

Authors:  T H Turpen; S J Reinl; Y Charoenvit; S L Hoffman; V Fallarme; L K Grill
Journal:  Biotechnology (N Y)       Date:  1995-01

10.  Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response.

Authors:  J Fitchen; R N Beachy; M B Hein
Journal:  Vaccine       Date:  1995-08       Impact factor: 3.641

View more
  44 in total

1.  Novel Approaches to Oral Vaccines: Delivery of Antigens by Edible Plants.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation.

Authors:  M Rosario Fernández-Fernández; Jorge L Martínez-Torrecuadrada; Fernando Roncal; Elvira Domínguez; Juan Antonio García
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 3.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

4.  Study of immunogenic properties of the candidate edible vaccine against human immunodeficiency and hepatitis B viruses based on transgenic tomato fruits.

Authors:  S N Shchelkunov; R K Salyaev; N I Rekoslavskaya; S G Pozdnyakov; A E Nesterov; V M Sumtsova; N V Pakova; U O Mishutina; T V Kopytina; R Hammond
Journal:  Dokl Biochem Biophys       Date:  2005 Mar-Apr       Impact factor: 0.788

5.  Immunization against rabies with plant-derived antigen.

Authors:  A Modelska; B Dietzschold; N Sleysh; Z F Fu; K Steplewski; D C Hooper; H Koprowski; V Yusibov
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 6.  Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.

Authors:  Sergio Rosales-Mendoza
Journal:  Mol Biotechnol       Date:  2015-10       Impact factor: 2.695

Review 7.  Mycoviruses: future therapeutic agents of invasive fungal infections in humans?

Authors:  W W J van de Sande; J R Lo-Ten-Foe; A van Belkum; M G Netea; B J Kullberg; A G Vonk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-02       Impact factor: 3.267

8.  In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector.

Authors:  G Zhang; C Leung; L Murdin; B Rovinski; K A White
Journal:  Mol Biotechnol       Date:  2000-02       Impact factor: 2.695

Review 9.  Tobacco mosaic virus and the virescence of biotechnology.

Authors:  T H Turpen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-03-29       Impact factor: 6.237

Review 10.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.